327 related articles for article (PubMed ID: 33499938)
1. "It's way more than just writing a prescription": A qualitative study of preferences for integrated versus non-integrated treatment models among individuals with opioid use disorder.
Saunders EC; Moore SK; Walsh O; Metcalf SA; Budney AJ; Cavazos-Rehg P; Scherer E; Marsch LA
Addict Sci Clin Pract; 2021 Jan; 16(1):8. PubMed ID: 33499938
[TBL] [Abstract][Full Text] [Related]
2. Evaluating preferences for medication formulation and treatment model among people who use opioids non-medically: A web-based cross-sectional study.
Saunders EC; Budney AJ; Cavazos-Rehg P; Scherer E; Bell K; John D; Marsch LA
J Subst Use Addict Treat; 2024 Aug; 163():209383. PubMed ID: 38670531
[TBL] [Abstract][Full Text] [Related]
3. Perceptions and preferences for long-acting injectable and implantable medications in comparison to short-acting medications for opioid use disorders.
Saunders EC; Moore SK; Walsh O; Metcalf SA; Budney AJ; Scherer E; Marsch LA
J Subst Abuse Treat; 2020 Apr; 111():54-66. PubMed ID: 32076361
[TBL] [Abstract][Full Text] [Related]
4. Patient perceptions of and experiences with stigma using telehealth for opioid use disorder treatment: a qualitative analysis.
Couch JV; Whitcomb M; Buchheit BM; Dorr DA; Malinoski DJ; Korthuis PT; Ono SS; Levander XA
Harm Reduct J; 2024 Jun; 21(1):125. PubMed ID: 38937779
[TBL] [Abstract][Full Text] [Related]
5. "The elephant in the room;" a qualitative study of perinatal fears in opioid use disorder treatment in Southern Appalachia.
Leiner C; Cody T; Mullins N; Ramage M; Ostrach BMM
BMC Pregnancy Childbirth; 2021 Feb; 21(1):143. PubMed ID: 33596843
[TBL] [Abstract][Full Text] [Related]
6. Experiences of care among individuals with opioid use disorder-associated endocarditis and their healthcare providers: Results from a qualitative study.
Bearnot B; Mitton JA; Hayden M; Park ER
J Subst Abuse Treat; 2019 Jul; 102():16-22. PubMed ID: 31202284
[TBL] [Abstract][Full Text] [Related]
7. The lived experiences and treatment needs of women with opioid use disorder and posttraumatic stress symptoms: A mixed methods study.
Saraiya TC; Helpinstill S; Gray D; Hien DA; Brady KT; Hood CO; Back SE
J Subst Use Addict Treat; 2024 Jun; 161():209344. PubMed ID: 38492805
[TBL] [Abstract][Full Text] [Related]
8. Treatment utilization among persons with opioid use disorder in the United States.
Wu LT; Zhu H; Swartz MS
Drug Alcohol Depend; 2016 Dec; 169():117-127. PubMed ID: 27810654
[TBL] [Abstract][Full Text] [Related]
9. Male patients' preferences for opioid use treatment programs.
Amini-Rarani M; Moeeni M; Ponnet K
BMC Psychiatry; 2023 Jun; 23(1):440. PubMed ID: 37328768
[TBL] [Abstract][Full Text] [Related]
10. Increasing access to quality care for pregnant and postpartum people with opioid use disorder: Coordination of services, provider awareness and training, extended postpartum coverage, and perinatal quality collaboratives.
Ellick KL; Kroelinger CD; Chang K; McGown M; McReynolds M; Velonis AJ; Bronson E; Riehle-Colarusso T; Pliska E; Akbarali S; Mueller T; Dronamraju R; Cox S; Barfield WD
J Subst Use Addict Treat; 2024 Jan; 156():209208. PubMed ID: 37939904
[TBL] [Abstract][Full Text] [Related]
11. Correlates of specialty substance use treatment among adults with opioid use disorders.
Romo E; Ulbricht CM; Clark RE; Lapane KL
Addict Behav; 2018 Nov; 86():96-103. PubMed ID: 29551551
[TBL] [Abstract][Full Text] [Related]
12. The unique nature of public stigma toward non-medical prescription opioid use and dependence: a national study.
Perry BL; Pescosolido BA; Krendl AC
Addiction; 2020 Dec; 115(12):2317-2326. PubMed ID: 32219910
[TBL] [Abstract][Full Text] [Related]
13. Posttraumatic stress disorder in people who use drugs: syringe services program utilization, treatment need, and preferences for onsite mental health care.
López-Castro T; Sohler N; Riback L; Bravo G; Ohlendorf E; Ghiroli M; Fox AD
Harm Reduct J; 2024 Jun; 21(1):108. PubMed ID: 38824597
[TBL] [Abstract][Full Text] [Related]
14. Provider perspectives on screening and treatment for opioid use disorder and mental health in HIV care: A qualitative study.
Knettel BA; Chen H; Wilson E; Agor D; McKellar MS; Reif S
PLoS One; 2024; 19(6):e0305174. PubMed ID: 38913659
[TBL] [Abstract][Full Text] [Related]
15. Trends in Urine Drug Monitoring Among Persons Receiving Long-Term Opioids and Persons with Opioid Use Disorder in the United States.
Sohn M; Talbert JC; Huang Z; Oser C; Freeman PR
Pain Physician; 2021 Mar; 24(2):E249-E256. PubMed ID: 33740362
[TBL] [Abstract][Full Text] [Related]
16. Perceived stigma, barriers, and facilitators experienced by members of the opioid use disorder community when seeking healthcare.
McCurry MK; Avery-Desmarais S; Schuler M; Tyo M; Viveiros J; Kauranen B
J Nurs Scholarsh; 2023 May; 55(3):701-710. PubMed ID: 36317787
[TBL] [Abstract][Full Text] [Related]
17. Behavioral health treatment utilization among individuals with co-occurring opioid use disorder and mental illness: Evidence from a national survey.
Novak P; Feder KA; Ali MM; Chen J
J Subst Abuse Treat; 2019 Mar; 98():47-52. PubMed ID: 30665603
[TBL] [Abstract][Full Text] [Related]
18. Developing a clinical decision support for opioid use disorders: a NIDA center for the clinical trials network working group report.
Bart GB; Saxon A; Fiellin DA; McNeely J; Muench JP; Shanahan CW; Huntley K; Gore-Langton RE
Addict Sci Clin Pract; 2020 Jan; 15(1):4. PubMed ID: 31948487
[TBL] [Abstract][Full Text] [Related]
19. "No more falling through the cracks": A qualitative study to inform measurement of integration of care of HIV and opioid use disorder.
Oldfield BJ; Muñoz N; Boshnack N; Leavitt R; McGovern MP; Villanueva M; Tetrault JM; Edelman EJ
J Subst Abuse Treat; 2019 Feb; 97():28-40. PubMed ID: 30577897
[TBL] [Abstract][Full Text] [Related]
20. Patient Barriers and Facilitators to Medications for Opioid Use Disorder in Primary Care.
Tofighi B; Williams AR; Chemi C; Suhail-Sindhu S; Dickson V; Lee JD
Subst Use Misuse; 2019; 54(14):2409-2419. PubMed ID: 31429351
[No Abstract] [Full Text] [Related]
[Next] [New Search]
